In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Editorial Advisory Board
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Guidelines for Contributors
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical Legal Issues Legal Issues

Supreme Court Puts Tools in Turmoil

Executive Summary

In a blow for tool companies and a boost for drug developers, the Supreme Court in June held that drug companies could--in specific circumstances--use tool patents without paying for them. The problem: no one knows just how much protection the ruling affords. Even drug-developing biotechs, who now get a freer hand with other companies' tools, aren't universally happy with the ruling.
Table

View full table

Advertisement

Related Content

Scrip
In RNAi, Technology Proliferates Beyond the Big Two
In Vivo
The Changing IP Landscape: Biopharma is the Battleground for Supreme Court Patent Assault
In Vivo
The Changing IP Landscape: Biopharma is the Battleground for Supreme Court Patent Assault

Topics

Related Companies

Advertisement
Tags:
BioPharmaceutical Legal Issues Legal Issues
UsernamePublicRestriction

Register

IV002652

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By